Overview
Clinical Benefits
- Increased libido
- Treats sexual dysfunction
- Works for both sexes
Administration
Subcutaneous injection 45 min before intended activity
Drug class: melanocortin agonist
Clinical Dosing
Typical dosage
1-2mg as needed
Starting dose
0.5mg
Cadence
As needed (max 8 doses/month)
Full titration schedule
| Phase | Dose |
|---|---|
| First use | 0.5mg to assess tolerance |
| Subsequent | 1mg as needed, 45 min before activity |
| Max | 1.75mg per dose, max 8 per month |
Safety Profile
Side effects
- • Nausea
- • Flushing
- • Headache
Contraindications
- • Uncontrolled hypertension
- • Cardiovascular disease
Featured in these stacks
Frequently asked questions
PT-141 (Bremelanotide) is most commonly researched for: Increased libido, Treats sexual dysfunction, Works for both sexes.
Ready to build a protocol with PT-141 (Bremelanotide)?
LIA, our clinical reasoning engine, will build a personalized protocol — dosing, cadence, cycling, and safety checks — tailored to your goals and intake.
You’ll be asked to sign in first. Free tier includes the chat preview.
Information on this page is for educational purposes only and is not medical advice. Peptides should only be used under the supervision of a qualified healthcare provider.